More than 200 preventive vaccines, developed by both industry and non-industry players

Technical advances, especially in the field of biotechnology, have led to the development of several next generation preventive vaccines, including recombinant vaccines, viral vector based vaccines and DNA vaccines, which have been demonstrated to elicit powerful immune responses, resulting in the development of immunological memory.
 
To order this 250+ page report, which features 85+ figures and 125+ tables, please visit this link
 
The USD 94 billion (by 2030) financial opportunity within the global preventive vaccine market has been analyzed across the following segments:
Route of Administration
  • Intramuscular
  • Subcutaneous
  • Oral
  • Intravenous
  • Others

Type of Vaccine
  • Pneumococcal Conjugate Vaccine
  • Human Papilloma Virus Vaccine
  • Rotavirus Vaccine
  • Influenza Vaccine
  • MMR Vaccine
  • Tetanus and Diphtheria Booster Vaccine
  • Varicella Vaccine
  • DTaP-Hib-IPV Vaccine
  • DTaP-HepB-Hib-IPV Vaccine
  • Others
Type of Vaccine API
  • Live, Attenuated Vaccine
  • Inactivated Vaccine
  • Conjugate Vaccine
  • Subunit Vaccine
  • Toxoid Vaccine
  • Others
Target Patient Population
Pediatric Patients
Adults
Key Players
GlaxoSmithKline
Merck
Sanofi Pasteur
Pfizer
Emergent BioSolutions
CSL
Others
Key Geographical Regions
North America
Europe
Asia Pacific
Rest of the World
 
The Global Preventive Vaccines Market, 2020-2030 report features the following companies, which we identified to be key players in this domain: 
Bio Farma
Emergent BioSolutions
GC Pharma
GlaxoSmithKline
Janssen
Merck
Novavax
Pfizer
Sanofi Pasteur
Valneva
 
Table of Contents
 
1. Preface

2. Executive Summary

3. Introduction


4. Market Landscape


5. Company Competitiveness Analysis


6. Company Profiles


7. Clinical Trial Analysis


8. Ongoing Vaccine Development Initiatives for Complex Conditions


9. Funding and Investment Analysis


10. Market Sizing and Opportunity Analysis


11. Case-in-Point: Contract Manufacturing of Vaccines


12. Concluding Remarks
13. Executive Insights
14. Appendix 1: Tabulated Data
15. Appendix 2: List of Companies and Organizations
 
To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/preventive-vaccines/318.html
 
Contact Details
Gaurav Chaudhary
+1 (415) 800 3415
[email protected]  

You may also like

Discussion

No comments yet... Be the first to leave a reply! Login here

avatar
BenJ
0 Karma
628 Posts

Made with by Mamby